From prayer times to family vigils, everyday realities can alter how delirium presents — and how clinicians should respond.
CeriBell (NASDAQ:CBLL) outlined its recent progress and 2026 priorities at a JPMorgan MedTech event, emphasizing continued ...
The Sunnyvale, CA-based firm's EEG-based solution uses artificial intelligence algorithms to identify large vessel occlusion ...
Ceribell announced today that the FDA granted breakthrough device designation for its large vessel occlusion (LVO) stroke ...
Medical Device Network on MSN
FDA grants breakthrough designation to Ceribell’s stroke detection tool
Ceribell’s LVO Stroke tool is underpinned by the same EEG monitoring technology used in its seizure and delirium monitoring ...
Roughly 25 percent of dementia patients were prescribed at least one ‘potentially inappropriate’ drug between 2013 and 2021 ...
The Mirror US on MSN
New study finds dementia patients have been prescribed drugs that can cause delirium
Researchers are sounding the alarm on dangerous stimulant medications commonly prescribed to dementia patients in the U.S.
MedPage Today on MSN
Risky Drugs Still in the Mix for Dementia Patients
CNS-active drugs are associated with an increased risk of falls, delirium, and hospitalization. They are often prescribed for ...
Roughly 25 percent of dementia patients were prescribed at least one ‘potentially inappropriate’ drug between 2013 and 2021 ...
Ceribell wins FDA Breakthrough status for its AI-driven EEG solution to detect and monitor LVO strokes in hospitals, boosting credibility and growth outlook.
Clearance would position the Ceribell System as the first and only point-of-care electroencephalography (EEG) technology to ...
Let’s be clear. The primary reason to be vaccinated against shingles is that two shots provide 90 percent protection against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback